Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yu, Xiaojuan ^a   Zhang, Senyan ^a   Jiang, Liwei ^b   Cui, Ye ^a   Li, Dongxia ^c   Wang, Dongli ^a   Wang, Nianshuang ^a   Fu, Lili ^b   Shi, Xuanlin ^b   Li, Ziqiang ^c   Zhang, Linqi ^b   Wang, Xinquan ^a,d  

^a TSINGHUA UNIVERSITY   (China)

^b Tsinghua University   (China)

^c BioDuro(Beijing)Co Ltd   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; PROTEIN BINDING; VIRUS ENVELOPE PROTEIN;

BINDING SITE; CHEMICAL MODEL; CHEMISTRY; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR DOCKING; STRUCTURE ACTIVITY RELATION; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; BINDING SITES; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MODELS, CHEMICAL; MOLECULAR DOCKING SIMULATION; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS;

EID: 84939545662     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13133     Document Type: Article

References (39)

1. Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. & Fouchier, R. A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367, 1814-1820 (2012).
2. de Groot, R. J. et al. Middle East Respiratory Syndrome Coronavirus (MERS-CoV); Announcement of the Coronavirus Study Group. J Virol 87, 7790-7792 (2013).
3. The Who Mers-Cov Research, G. State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERSCoV) in Humans. PLoS Curr 5, doi: 10.1371/ecurrents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8 (2013).
4. Bermingham, A. et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill 17, 20290 (2012).
5. Memish, Z. A., Zumla, A. I., Al-Hakeem, R. F., Al-Rabeeah, A. A. & Stephens, G. M. Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections. N Engl J Med 368, 2487-2494 (2013).
6. Assiri, A. et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13, 752-761 (2013).
7. Hijawi, B. et al. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J 19 Suppl 1, S12-18 (2013).
8. Assiri, A. et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369, 407-416 (2013).
9. Guery, B. et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 381, 2265-2272 (2013).
10. Woo, P. C. Y., Lau, S. K. P., Li, K. S. M., Tsang, A. K. L. & Yuen, K.-Y. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerging Microbes & Infections 1, e35 (2012).
11. van Boheemen, S. et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3, e00473-12, doi: 10.1128/mbio.00473-12 (2012).
12. Lau, S. K. et al. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 87, 8638-8650 (2013).
13. Memish, Z. A. et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19, 1819-1823 (2013).
14. Ithete, N. L. et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis 19, 1697-1699 (2013).
15. Reusken, C. B. et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13, 859-866 (2013).
16. Hemida, M. G. et al. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis 20, 1231-1234 (2014).
17. Haagmans, B. L. et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 14, 140-145 (2014).
18. Peiris, J.S.M., Guan, Y. & Yuen, K.Y. Severe acute respiratory syndrome. Nat Med 10, S88-S97 (2004).
19. Cauchemez, S. et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 14, 50-56 (2014).
20. Breban, R., Riou, J. & Fontanet, A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 382, 694-699 (2013).
21. Masters, P. S. The molecular biology of coronaviruses. Adv Virus Res 66, 193-292 (2006).
22. Raj, V. S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251-254 (2013).
23. Jiang, S., Lu, L., Du, L. & Debnath, A. K. A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC. J Infect 66, 464-466 (2013).
24. Mou, H. et al. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol 87, 9379-9383 (2013).
25. Wang, N. et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 23, 986-993 (2013).
26. Lu, G. et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500, 227-231 (2013).
27. Jiang, L. et al. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med 6, 234ra259, doi: 10.1126/scitranslmed.3008140 (2014).
28. Tang, X. C. et al. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci USA 111, E2018-2026 (2014).
29. Ying, T. et al. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol 88, 7796-7805 (2014).
30. Du, L. et al. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein. J Virol 88, 7045-7053 (2014).
31. Chen, Y. et al. Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J Virol 87, 10777-10783 (2013).
32. Yang, Y. et al. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci USA 111, 12516-12521 (2014).
33. Wang, Q. et al. Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26. Cell Host Microbe 16, 328-337 (2014).
34. Otwinowski, Z. Minor, W. Processing of X-ray diffraction data collected in oscillation mode Method. Enzymol. 276, 307-326 (1997).
35. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
36. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948-1954 (2002).
37. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
38. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291 (1993).
39. DeLano, W. L. Pymol Molecular Graphics System. DeLano Scientific, San Carlos, California, USA (2002).